You just read:

New Data Show Proleukin® (aldesleukin) Improves Patient Outcomes as First-Line Therapy for the Treatment of Patients with Metastatic Melanoma or Metastatic Renal Cell Carcinoma

News provided by

Prometheus Laboratories Inc.

May 15, 2015, 08:00 ET